'Cruel and heartless': $52k annual tax on 'miracle drug' slammed
'We will do anything to keep our boy alive but ... detest having to pay tax to do so.'
AdvertisementAdvertise with NZME.
Latest fromPharmaceuticals
'We still wait, and die, for our miracle drug - why?'
OPINION: 'Trikafta makes cystic fibrosis a manageable condition. It lets people live.'
Douglas Pharmaceuticals' new $50m block opens
Hi-tech lab and skybridge in major new R&D site.
US pharmacy chains fined $1b over opioid crisis in communities
Jury says pharmacies played a massive role in creating a public nuisance.
Rua Bioscience CEO Rob Mitchell to retire
Rua director Anna Stove will lead the business as managing director.
Focus live: Andrew Little's Andrew Little's response to Pharmac inquiry
Health Minister Andrew Little said Pharmac in future will have more focus on improving the health of Māori, Pacific peoples and disabled people. Video / Mark Mitchell
'It saves lives': Kristie Purton could still be alive if Trikafta was available
The second 'Cystic Sister' died in 2019 from cystic fibrosis.
Health reforms review divided over Māori role
The special committee examining the Govt's health reforms has completed its final report.
Medsafe warning after quack Covid 'cure' puts person in ICU
Drinking Miracle Mineral Solution is dangerous and it doesn't cure Covid, Medsafe says.
Comment: Shh... medicinal cannabis is making a difference
OPINION: Medicines Act prohibits advertising medicinal cannabis, or even talking about it.
Desperate pharmacist on denying RATs to sick: 'I just feel so helpless'
A pharmacist says countless symptomatic people are seeking tests she can't give out.
South Auckland GPs call for new anti-viral drugs
Almost 50 per cent of all current Covid-19 cases in NZ are in Counties Manukau district.
Parents taking Government to court to stop vaccine rollout for kids
Group says the approval of Pfizer's vaccine for kids was flawed and illegal.
Parents lose daughter to meningococcal, now fighting for access to vaccines
Parents Mark and Lisa Gallagher lost their daughter Letitia to meningococcal C in 2012. Video / Ministry of Health
Drugmaker Teva found liable in opioid crisis
A separate trial will follow to determine what Teva will have to pay in the case.
Opinion: Why you'll be hearing more about cannabis, bud
OPINION: Mark Dye explains why dried cannabis flowers will a hot topic in the near future.
Watch: Experts explain 'gamechanger' treatments for Covid
They've been described as "gamechangers" in the fight against Covid-19.
Pfizer says booster protects against Omicron
Pharma claims booster increases people's levels of antibodies by 25-fold.
'Damning' Pharmac report reveals 'fortress mentality' to decision-making
It also questions commitments to equity; just four of its nearly 150 staff are Māori.
First wahine Māori to head Pharmac advisory board
Dr Jane Thomas to lead Pharmacology and Therapeutics Advisory Committee from December.
AFT Pharmaceuticals signals future dividend as revenue, profits improve
The company will consider a dividend policy once it meets a net debt target.
Pfizer releases anti-viral pill to other makers
Health officials hope the deal could help to end the pandemic sooner.
Opinion | Give Kiwis with cystic fibrosis a future
OPINION: Christine Perrins puts the case for Pharmac to fund a life-changing treatment.
Pfizer asks US to approve vaccine for ages 5-11
Plan to ship lower-dose vials, especially marked for use in children.
Manukau supermarket among latest Auckland locations of interest
People who were at this location must isolate and get tested immediately, authorities say.
Meet Fifi, the llama whose antibodies could hold the key to fighting Covid
Coronavirus treatment made from llama nanobodies 'one of the most effective ever tested'.
Opinion | Your 'free' jab will save lives
OPINION: Graeme Jarvis writes vaccine development is more expensive than rocket science.
Opinion | How 'free' Covid jabs are making the mega-rich richer
OPINION: Nations paying between 4 and 24 times more than the cost of producing vaccines.
Opinion | The value of a New Zealander's life
OPINION: Why is a life saved from Covid-19 worth more than one saved from other illnesses?
James McGoram: Why medicine funding doesn't fit into the 'trolley problem' basket
Opinion: Saying some people are going to die is a failure of both empathy and imagination.
150 jobs going as pharma company closes Manukau site
Pharma company is closing sites in South Auckland that have operated since the 1990s.
Pharmac: Is our medicines agency still fit for purpose?
Agency's future is under scrutiny as it juggles public demands and rising drug prices.
Dying man's father hits out at Government funding gangs, not drugs
Justin Haigh is paying hundreds of thousands for unfunded, potentially life-saving drugs.
Pharmac releases priority funding lists for first time
The release comes after public pressure for the agency to be more transparent.